20172023

Research activity per year

Personal profile

Biography

Dr Parker is an Early Career Research Fellow at Monash University in the Transfusion Research Unit and holds research interests in patient experience and outcomes, utilising qualitative and mixed-methods expertise to provide novel insights. 

Dr Parker’s PhD, in the field of acute myeloid leukaemia survivorship care examined financial burden using a mixed methods study design.  Dr Parker has had a diverse career before academia in diagnostic laboratories, before moving into clinical trials and policy and advocacy with roles in both private and not-for-profit organisations. Dr Parker has led a number of policy initiatives and research to improve cancer care and the experiences of patients and is passionate about embedding and increasing the profile of the patient lived experience in research and clinical trials. Dr Parker been awarded more than $6 million in funding with $2.4 million in funding as either Primary Chief Investigator or Chief Investigator. They are an associate investigator on the NHMRC-supported RATIONALISE study (NCT05678621) co-leading a nested qualitative study within the RCT exploring patient perspectives on the use of immunoglobulin and oral antibiotics. 

Dr Parker is actively engaged with the oncology and haematology community through membership and committees with the Australasian Lymphoma and Leukaemia Group (Supportive Care Committee), the American Society of Clinical Oncology (ASCO), the Multinational Association of Supportive Cancer in Care (MASCC) (Supportive Care and Palliative Care committees) and the Australian and New Zealand Society of Blood Transfusion (ANZSBT).

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or